180 related articles for article (PubMed ID: 16672771)
41. The effect of curcumin on corneal neovascularization in rabbit eyes.
Kim JS; Choi JS; Chung SK
Curr Eye Res; 2010 Apr; 35(4):274-80. PubMed ID: 20373893
[TBL] [Abstract][Full Text] [Related]
42. [A synthetic peptide selected by bioinformatics inhibits mouse corneal neovascularization].
Zhao H; Yi ZF; Hu HH; Xu X
Zhonghua Yan Ke Za Zhi; 2007 Feb; 43(2):151-7. PubMed ID: 17459247
[TBL] [Abstract][Full Text] [Related]
43. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
Murata M; Shimizu S; Horiuchi S; Taira M
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):205-9. PubMed ID: 16044325
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
Deissler HL; Deissler H; Lang GE
Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
[TBL] [Abstract][Full Text] [Related]
47. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
48. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
49. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor.
Qian RZ; Yue F; Zhang GP; Hou LK; Wang XH; Jin HM
Chin Med J (Engl); 2008 Dec; 121(24):2599-603. PubMed ID: 19187602
[TBL] [Abstract][Full Text] [Related]
50. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
Lee YK; Chung SK
Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
52. Corneal neovascularization suppressed by TIMP2 released from human amniotic membranes.
Ma X; Li J
Yan Ke Xue Bao; 2005 Mar; 21(1):56-61. PubMed ID: 17162918
[TBL] [Abstract][Full Text] [Related]
53. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin.
Shin SH; Kim JC; Chang SI; Lee H; Chung SI
Cornea; 2000 Mar; 19(2):212-7. PubMed ID: 10746455
[TBL] [Abstract][Full Text] [Related]
54. Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization.
Kuo CN; Chen CH; Chen SN; Huang JC; Lai LJ; Lai CH; Hung CH; Lee CH; Chen CY
Int Ophthalmol; 2018 Apr; 38(2):747-756. PubMed ID: 28393322
[TBL] [Abstract][Full Text] [Related]
55. VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.
Oliveira HB; Sakimoto T; Javier JA; Azar DT; Wiegand SJ; Jain S; Chang JH
Eur J Ophthalmol; 2010; 20(1):48-54. PubMed ID: 19882518
[TBL] [Abstract][Full Text] [Related]
56. Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea.
Tamada Y; Fukiage C; Boyle DL; Azuma M; Shearer TR
J Ocul Pharmacol Ther; 2000 Jun; 16(3):271-83. PubMed ID: 10872924
[TBL] [Abstract][Full Text] [Related]
57. Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization.
Lopez ES; Rizzo MM; Croxatto JO; Mazzolini G; Gallo JE
Cancer Chemother Pharmacol; 2011 Mar; 67(3):723-8. PubMed ID: 20857116
[TBL] [Abstract][Full Text] [Related]
58. Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model.
Gaudric A; N'guyen T; Moenner M; Glacet-Bernard A; Barritault D
Ophthalmic Res; 1992; 24(3):181-8. PubMed ID: 1407961
[TBL] [Abstract][Full Text] [Related]
59. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
Cano Mdel V; Karagiannis ED; Soliman M; Bakir B; Zhuang W; Popel AS; Gehlbach PL
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3840-5. PubMed ID: 19279315
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of experimental angiogenesis of cornea by somatostatin.
Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
